Real-world provider experiences with hemophilia A gene therapy: administration of valoctocogene roxaparvovec.
- DOI
- 10.1016/j.rpth.2026.106626
- Published
- 2026 May
- Container
- Research and practice in thrombosis and haemostasis
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.rpth.2026.106626,
title = {Real-world provider experiences with hemophilia A gene therapy: administration of valoctocogene roxaparvovec.},
author = {Peyvandi F and Klamroth R and Oldenburg J and Rajasekhar A and Buxton A and Di Minno MND and Gottstein S and Soni A and Zanon E and Leavitt AD},
year = {2026},
journal = {Research and practice in thrombosis and haemostasis},
doi = {10.1016/j.rpth.2026.106626},
url = {https://doi.org/10.1016/j.rpth.2026.106626}
}RIS
TY - JOUR TI - Real-world provider experiences with hemophilia A gene therapy: administration of valoctocogene roxaparvovec. AU - Peyvandi F AU - Klamroth R AU - Oldenburg J AU - Rajasekhar A AU - Buxton A AU - Di Minno MND AU - Gottstein S AU - Soni A AU - Zanon E AU - Leavitt AD PY - 2026 JO - Research and practice in thrombosis and haemostasis DO - 10.1016/j.rpth.2026.106626 UR - https://doi.org/10.1016/j.rpth.2026.106626 ER -
APA
F, P., R, K., J, O., A, R., A, B., MND, D. M., S, G., A, S., E, Z., & AD, L. (2026). Real-world provider experiences with hemophilia A gene therapy: administration of valoctocogene roxaparvovec.. Research and practice in thrombosis and haemostasis. https://doi.org/10.1016/j.rpth.2026.106626
Source records
- pubmed · retrieved 2026-09-26T09:19:49.378Z